Resistance to the clinically significant carbapenem antibiotics
by enzymatic hydrolysis has been described in Enterobacteriaceae worldwide, and recently the class D [beta]-lactamase, OXA-48 and its variants have been detected more frequently.
S-649266 has demonstrated active penetration into bacteria and stability to beta-lactamases that hydrolyze carbapenem antibiotics
, according to results presented at IDWeek 2014.
Our primary focus is helping to identify bacteria that are resistant to powerful carbapenem antibiotics
The publication of the toolkit on how to manage a particular type of antibiotic resistant bacteria called carbapenemase-producing Enterobacteriaceae which is an area of concern as bacteria with this mechanism are resistant to carbapenem antibiotics
which are those usually used as last resort .
According to the report, resistance to the treatment of last resort for life- threatening infections caused by a common intestinal bacteria, Klebsiella pneumonia -- carbapenem antibiotics
-- has spread to the entire world.
Key findings from the report included that resistance to the treatment of last resort for life-threatening infections caused by a common intestinal bacteria, Klebsiella pneumoniae carbapenem antibiotics
has spread to all regions of the world.
Prof Neil Woodford, of Public Health England, said: "KPC is one of a number of enzymes that can make a bacteria resistant to carbapenem antibiotics
In some parts of the world, only the carbapenem antibiotics
class remains effective, but now signs are emerging of resistance even to this last line of defence.
In-vitro activity of carbapenem antibiotics
against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.
Key Topics Covered: - China Antibiotics Market In Globalization Process, 2009 - China Antibiotics Foreign Trade, 2007-2008 - China Antibiotics Market, 2008 - China Antibiotics Market after 2010 - China Anti-Infective Drug Market - China Antibiotics Retail Market - Children Oral Antibiotics Market - Cephalosporins Antibiotics Market - Penicillin Antibiotics Market - Carbapenem Antibiotics
Market - Macrolide Antibiotics Market - Quinolones Antibiotics Market - Beta-lactams Antibiotics Market - Polypeptide Antibiotics Market - Market Competition - List of Charts Companies Mentioned: - Yangtze River Pharmaceutical Group - Shanghai Roche Pharmaceuticals Co.
In some countries, because of resistance, carbapenem antibiotics
will not work in more than half of people treated for K.
Carbapenemase-producing organisms were named for their ability to fight off carbapenem antibiotics
- the last line of defense in our medical toolbox," said John Bishop, Cepheid's Chairman and Chief Executive Officer.